Biotech grants in the United States

Between cycles

Funds high-risk, high-reward pancreatic cancer research ideas, with an optional funding boost for pairing an early-career investigator with a mentor.

Between cycles

Funds a required clinician-scientist partnership in pancreatic cancer research, the only sibling award here that allows a pilot clinical trial.

Between cycles

Funds cancer clinical trials from first-in-human through phase III, with regulatory filings already due at the application deadline.

Between cycles

Funds untested, high-risk basic cancer research ideas, explicitly excluding incremental advances or a model swapped from one cancer to another.

Between cycles

Funds a clinical trial in one of the year's congressionally named disease topics, sized by phase into three cost tiers.

Between cycles

Funds a multi-investigator platform product through translational and early-phase trials, with each partnering investigator on a separate award.

Between cycles

Funds computational and AI research that mines large prostate cancer datasets for insight, not new lab experiments.

Between cycles

Funds a first prostate cancer research project for a scientist within three years of their postdoc, guided by an experienced mentor.

Between cycles

Funds innovative prostate cancer research ideas, open to established investigators and to new ones paired with an experienced collaborator.

Between cycles

Funds a mentored research project for a physician moving from clinical duties into a prostate cancer research career.

Between cycles

Funds an untested, high-risk idea in rare cancers, judged with no names attached to keep the review blind.

Between cycles

Supports United States defense innovators in AI, aerospace, and advanced systems development.

Between cycles

Supports United States innovation teams in strategic technology areas across security and digital fields.

Between cycles

Funds a conceptually new, unproven idea in tick-borne disease research — not an incremental step on work that is already published or underway.

Between cycles

Funds either a drug-discovery study or a clinical diagnostic approach for Lyme disease and other tick-borne diseases, aimed at something a clinic could use.

Between cycles

Funds a clinical trial for psychological health conditions or traumatic brain injury, at a pilot or a larger effectiveness scale the applicant chooses.

Between cycles

Funds translational research turning brain-injury or psychological-health findings into a real clinical application — short of running a clinical trial.

Between cycles

Funds ovarian cancer research from basic lab work through translational studies, with clinical trials excluded and preliminary data required.

Between cycles

Funds an early-career investigator's place in a mentored ovarian cancer research academy, with mentors, a dean and monthly webinars.

Between cycles

Funds an early-career investigator's clinical-trial training inside a mentored ovarian cancer trial academy, with a 25% effort commitment.

Between cycles

Funds an innovative, unproven ovarian cancer idea through a blinded pre-application that hides who is proposing it.

Between cycles

Funds mature cancer research with near-term clinical potential; trials are allowed but not required, unlike its Clinical Trial Award sibling.

Between cycles

Funds Duke BME and clinical faculty teams translating bioengineering research toward patient benefit and commercial products.

Between cycles

Invests research teams and institutions for EB Research Project Grants in biotechnology, medical technology, and synthetic biology.